NCT05543954View on ClinicalTrials.gov

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 3, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lung Neoplasms
Interventions
DRUG

68Ga-FAPI-RGD

Intravenous injection of 68Ga-FAPI-RGD with a dosage of approximately 1.8-2.2 MBq (0.05-0.06 mCi)/kg.

DRUG

18F-FDG

Intravenous injection of 18F-FDG with a dosage of approximately 3.7-5.55 MBq (0.1-0.15 mCi)/kg.

DRUG

68Ga-FAPI

Intravenous injection of 68Ga-FAPI with a dosage of approximately 1.8-2.2 MBq (0.05-0.06 mCi)/kg.

DRUG

68Ga-RGD

Intravenous injection of 68Ga-RGD with a dosage of approximately 1.8-2.2 MBq (0.05-0.06 mCi)/kg.

Trial Locations (1)

Unknown

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER